Edition:
United Kingdom

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

22.28USD
9:00pm BST
Change (% chg)

$0.33 (+1.50%)
Prev Close
$21.95
Open
$21.87
Day's High
$22.53
Day's Low
$21.61
Volume
42,498
Avg. Vol
75,199
52-wk High
$37.73
52-wk Low
$19.13

Select another date:

Fri, Mar 1 2019

EU committee approves Akcea-Ionis drug for rare genetic disease

March 1 An advisory committee of the European Medicines Agency (EMA) on Friday recommended conditionally approving a drug from Akcea Therapeutics Inc and Ionis Pharmaceuticals Inc that aims to treat a rare genetic disease that causes fat accumulation in the blood.

BRIEF-Akcea Therapeutics Says Co Will Receive A $150 Mln License Fee That Will Be Split Equally With Ionis

* AKCEA-APO(A)-LRX ADVANCES AS LEADING PHARMACEUTICAL COMPANY EXERCISES OPTION TO LICENSE

Select another date: